Back to search
FDAFDA · Food and drugs·Recall number D-0095-2019

Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA. NDC carton: 0409-3506-01; NDC vial: 0409-3506-11

Published October 31, 2018 · Recall initiated: September 20, 2018

Summary

FDA records drug Class II recall D-0095-2019, published October 31, 2018 and initiated September 20, 2018. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 71,075 vials; Lot: Lot: 609G047, EXP 10/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: loss of container integrity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
Nationwide in the US and Puerto Rico
Lot
Lot: 609G047, EXP 10/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA. NDC carton: 0409-3506-01; NDC vial: 0409-3506-11 recalled?

Yes. FDA published recall D-0095-2019 on October 31, 2018. Reported hazard: Lack of assurance of sterility: loss of container integrity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter